Skip to content

Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*

Jon E. Sprague, Petra Moze, David Caden, Daniel E. Rusyniak, Courtney Holmes, David S. Goldstein, Edward Mills

Critical Care Medicine June 1, 2005 DOI: 10.1097/01.ccm.0000165969.29002.70 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical study Peer reviewed
Topics MDMA
Keywords Hyperthermia Carvedilol Pharmacology Rhabdomyolysis Nadolol Catecholamine Adrenergic antagonist Rasagiline Hypothermia Anesthesia Citalopram Propranolol Endocrinology
Citations 75
Key points Alpha1 and beta3-adrenergic receptors may contribute to MDMA-induced hyperthermia, and drugs targeting these receptors, such as carvedilol, warrant further investigation as treatments.

Abstract

These data show that alpha1 and beta3-adrenergic receptors may contribute to the mediation of MDMA-induced hyperthermia and that drugs targeting these receptors, such as carvedilol, warrant further investigation as novel therapies for the treatment of psychostimulant-induced hyperthermia and its sequelae.

Comparable studies

Other preclinical and animal studies on MDMA, most cited first.

Citations in the library

Cited by 29

and 24 more in the library

Cites 9

and 4 more in the library

Explore topics